AI-generated summary
The authors report a randomized, double-blind, placebo-controlled trial of 74 young adults with subthreshold depression receiving 8 weeks of bright light therapy or placebo. The bright light group showed greater reductions in depression scores and increased brain connectivity between midbrain nuclei and frontal cortex regions, with baseline dorsal raphe-medial prefrontal connectivity linked to symptom change. These findings are associational and imaging-based.
- Participants
- 74
- Who or what was studied
- Young adults with subthreshold depression symptoms
- Limits stated in the abstract
- The abstract does not report the light wavelength or intensity used, and the findings are correlational with a relatively small sample split across two arms.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.apa.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Depression, Bright light therapy, Functional magnetic resonance imaging, Placebo-controlled, Biomarker. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.